The deregulation of ANGPTL4 is of particular interest, since its secreted product has been associated with cancer cell invasion and metastasis and is present in substantial amounts in the malignancy-associated ascites of most serous ovarian carcinoma patients (Figure 3F). The gene discussed is ANGPTL4; the disease is ovarian serous carcinoma.